Medicare already covers GLP-1s for non-weight-loss indications, with spending on Ozempic alone reaching $4.6 billion in 2022
Pairing these items with a protein or fat can also help slow down blood sugar rising
While traditional GLP-1 drugs personal injury lawsuits target pharmaceutical manufacturers, claims involving compounded versions may focus on compounding pharmacies or prescribing physicians
Dosing should always start low and increase gradually
The information shared is not a substitute for professional medical advice, diagnosis, or treatment
Promotes Satiety As an incretin hormone 11 , GLP-1 promotes satiety through both the central nervous system (CNS), which involves the brain and spinal cord, and peripheral pathways, which refer to processes or parts outside of the CNS